What drove SKIN.SW stock higher pre-market today?

SKIN.SW stock rose pre-market on 11 Mar 2026 due to a volume surge to **2,756** shares and a gap above the 50-day average (**CHF34.37**). The move reflects momentum traders and possible news or positioning ahead of pipeline updates.

What is Meyka AI's view and rating on SKIN.SW stock?

Meyka AI rates SKIN.SW **62.66/100 (B, HOLD)**. The score balances sector comparison, financial growth and analyst signals. The model projects **CHF44.00** in 12 months, with model risks noted; this is not investment advice.

What are the key technical levels for SKIN.SW stock to watch?

Key technicals: support at **CHF32.00** and the 50-day average **CHF34.37**. Near-term resistance is the 200-day average **CHF37.22** and the intraday high **CHF36.00**. Volume above **3,000** would confirm breakout strength.

How do SKIN.SW financials affect its outlook?

SKIN.SW shows trailing EPS **-1.27**, high PB (**26.30**) and limited revenue per share. These metrics make the stock sensitive to clinical outcomes and funding signals. Solid cash management and positive trials would improve valuation prospects.

CH Stocks

SKIN.SW Cassiopea S.p.A. (SIX) up 9.85% pre-market to CHF35.70: watch 50-day signal 11 Mar 2026

ByHuzaifa Zahoor March 11, 2026March 11, 2026

SKIN.SW stock jumped 9.85% pre-market to CHF35.70 on 11 Mar 2026 after an opening print at CHF32.00 and intraday highs of CHF36.00. Volume at 2,756 shares is about 1.52x the 3-month average of 1,818 shares, marking high-volume mover status in the Swiss SIX session. Traders are watching the gap above the 50-day average (CHF34.37) for a short-term trend shift. We examine fundamentals, technicals, Meyka AI grade and a model forecast to frame trading and risk points for Cassiopea S.p.A.